## Abstract The adaptor protein Grb10 is an interacting partner of the IGF‐I receptor (IGF‐IR) and the insulin receptor (IR). Previous work from our laboratory has established the role of Grb10 as a negative regulator of IGF‐IR‐dependent cell proliferation. We have shown that Grb10 binds the E3 ubi
Grb10 adapter protein as regulator of insulin-like growth factor receptor signaling
✍ Scribed by Andrea Morrione
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 172 KB
- Volume
- 197
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Grb10 is a member of a superfamily of adapter proteins that includes Grb10, 7, 14, and a protein of Caenorhabditis elegans called Mig10. Grb10 proteins are binding partners for several trans‐membrane tyrosine‐kinase receptors, including the insulin‐like growth factor receptor (IGF‐IR) and the insulin receptor (IR). Many recent reports have suggested a very important role of Grb10 in regulating IGF‐IR signaling. In this review, we will focus on the role of Grb10 in IGF‐I‐induced mitogenesis and we will discuss the recent findings that show the involvement of Grb10 in the regulation of ligand‐induced ubiquitination, internalization, and stability of the IGF‐IR. J. Cell. Physiol. 197: 307–311, 2003© 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Previously we have shown that transforming growth factor b (TGF b) 1, basic fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) BB inhibit the synthesis of insulin-like growth factor (IGF) II, but their effects on IGF binding protein (IGFBP)-6 in osteoblast cultures are not kno
## Gonadal hormones interact with in- sulin-like growth factor-I (IGF-I) to regulate synaptic plasticity during the estrous cycle in the rat mediobasal hypothalamus. It has been proposed that tanycytes, specialized glial cells lining the ventral region of the third ventricle, may regulate the avail
The role of insulin-like growth factor-I (IGF-I) in regulating estrogen receptor-␣ (ER-␣) gene expression and activity was investigated in the human breast cancer cell line MCF-7. Treatment of cells with 40 ng/ml IGF-I resulted in a 60% decrease in ER-␣ protein concentration by 3 h, and the amount o